Victory Capital Management
CABA icon

Victory Capital Management’s Cabaletta Bio CABA Stock Holding History

Victory Capital Management’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.3K Buy
+16,490
New +$54.2K ﹤0.01% 2395
2024
Q4 		– Sell
-629,087
Closed -$2.97M – 2482
2024
Q3 		$2.97M Sell
629,087
-5,130
-0.8% -$29.7K ﹤0.01% 1384
2024
Q2 		$4.74M Buy
634,217
+262,594
+71% +$3.22M ﹤0.01% 1255
2024
Q1 		$6.34M Sell
371,623
-32,304
-8% -$693K 0.01% 1184
2023
Q4 		$9.17M Buy
403,927
+337,277
+506% +$5.67M 0.01% 1086
2023
Q3 		$1.01M Buy
66,650
+6,980
+12% +$95.4K ﹤0.01% 1647
2023
Q2 		$770K Buy
+59,670
New +$648K ﹤0.01% 1799
2022
Q4 		– Sell
-42,586
Closed -$28K – 2604
2022
Q3 		$28K Sell
42,586
-115
-0.3% -$138 ﹤0.01% 2606
2022
Q2 		$45K Buy
42,701
+42
+0.1% +$59 ﹤0.01% 2557
2022
Q1 		$59K Sell
42,659
-221,565
-84% -$579K ﹤0.01% 2582
2021
Q4 		$1M Buy
264,224
+44,438
+20% +$474K ﹤0.01% 1829
2021
Q3 		$2.67M Buy
219,786
+171,529
+355% +$1.58M ﹤0.01% 1495
2021
Q2 		$415K Sell
48,257
-2,173
-4% -$21.4K ﹤0.01% 2295
2021
Q1 		$560K Sell
50,430
-46
-0.1% -$562 ﹤0.01% 2151
2020
Q4 		$630K Sell
50,476
-836
-2% -$10.8K ﹤0.01% 1960
2020
Q3 		$556K Sell
51,312
-20,201
-28% -$232K ﹤0.01% 1920
2020
Q2 		$797K Sell
71,513
-733
-1% -$5.61K ﹤0.01% 1826
2020
Q1 		$527K Sell
72,246
-2,754
-4% -$37.8K ﹤0.01% 1823
2019
Q4 		$1.05M Buy
+75,000
New +$889K ﹤0.01% 1739

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Victory Capital Management's CABA Position: Q2 2026 in Review

Victory Capital Management opened a new position in Cabaletta Bio (CABA) in Q2 2026: 16,490 shares worth $51.3K. The stake represents ﹤0.01% of the portfolio and ranks #2395 among its holdings. This is a return to the name: Victory Capital Management previously reported a position in CABA as recently as Q3 2024.

Victory Capital Management first reported a position in CABA in Q4 2019 and has held it in 19 quarters since. The position peaked at $9.17M in Q4 2023. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Victory Capital Management held 16,490 shares of Cabaletta Bio worth $51.3K as of Q2 2026.
  • Cabaletta Bio was a new Victory Capital Management position in Q2 2026.
  • Cabaletta Bio made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #2395 holding.
  • Victory Capital Management first reported a position in Cabaletta Bio in Q4 2019 and has held it in 19 quarters since.
  • Victory Capital Management's Cabaletta Bio position peaked at $9.17M in Q4 2023.
  • 140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.